SCHEMBL7846078

SCHEMBL7846078

O=c1nc2ccccc2cnc1-c1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
GLA P06280 1/20 0.50
PDE10A Q9Y233 1/20 0.47
ELANE P08246 4/20 0.43
CNR1 P21554 3/20 0.43
KMT2A Q03164 2/20 0.41
GUSB P08236 1/20 0.41
C1R P00736 1/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ABL1 P00519 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530110 0.81 MBNL1 (0.50) KDM4EALDH1A1PDE10AELANEC1R
SCHEMBL1651399 0.76 PDE10A (0.44) KDM4EALDH1A1GLAPDE10AKMT2A
SCHEMBL28110411 0.76 CYP1A2 (0.56) KDM4EALDH1A1GLAPDE10AKMT2A
SCHEMBL6545475 0.71 KDM4E (0.44) KDM4EALDH1A1GLAELANECNR1
SCHEMBL9187882 0.71 MEN1 (0.50) KDM4EALDH1A1GLAPDE10AKMT2A
SCHEMBL8776689 0.70 ALDH1A1 (0.43) KDM4EALDH1A1GLAPDE10AELANE
SCHEMBL8775144 0.69 CYP1A2 (0.44) KDM4EALDH1A1GLAPDE10AELANE
SCHEMBL3170374 0.68 ALDH1A1 (0.43) KDM4EALDH1A1GLAKMT2ANPC1
SCHEMBL3244662 0.68 KDM4E (0.41) KDM4EALDH1A1GLA
SCHEMBL11389060 0.68 KDM4E (0.41) KDM4EALDH1A1GLAKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089981-A1 COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS. Elan Pharmaceuticals, Inc. (US) 2001-04-11 EP disclosed
WO-1999067220-A1 COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS ELAN PHARMACEUTICALS, INC. (US) 1999-12-29 WO disclosed